VTGN - VistaGen readies 12M-share secondary offering

• VistaGen ( NASDAQ: VTGN ) down 4.3% premarket after filing a prospectus to sell 12.4M common shares by selling stockholders.
• The company will not receive any proceeds from the sale of the shares offered.
• This prospectus does not necessarily mean that the selling stockholders will offer or sell those shares.
• Recently, VTGN secured new U.S. patent for PH80 nasal spray for migraine.
• SEC Form S-3

For further details see: